Cargando…
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease
Circulating fatty acid composition is assumed to play an important role in metabolic dysfunction-associated fatty liver disease (MAFLD) pathogenesis. This study aimed to investigate the association between the overall balance of serum fatty acid composition and MAFLD prevalence. This cross-sectional...
Autores principales: | Nagase, Yuka, Satoh, Takao, Shigetome, Keiichi, Tokumaru, Naoto, Matsumoto, Erika, Yamada, Kazunori D., Imafuku, Tadashi, Watanabe, Hiroshi, Maruyama, Toru, Ogata, Yasuhiro, Yoshida, Minoru, Saruwatari, Junji, Oniki, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960614/ https://www.ncbi.nlm.nih.gov/pubmed/36839168 http://dx.doi.org/10.3390/nu15040809 |
Ejemplares similares
-
Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals
por: Sakamoto, Yuki, et al.
Publicado: (2019) -
A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population
por: Muto, Narumi, et al.
Publicado: (2020) -
Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond‐Forming Oxidoreductase A‐Like Protein (DsbA‐L) Polymorphism on the Weight Status
por: Oniki, Kentaro, et al.
Publicado: (2018) -
Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects
por: Oniki, Kentaro, et al.
Publicado: (2015) -
Additive Effects of Drinking Habits and a Susceptible Genetic Polymorphism on Cholesterol Efflux Capacity
por: Matsumoto, Erika, et al.
Publicado: (2023)